Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production
- PMID: 16320327
- DOI: 10.1002/art.21425
Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production
Abstract
Objective: To elucidate the role of nurse-like cells (NLCs) obtained from rheumatoid arthritis (RA) patients in bone loss during progressive synovial expansion.
Methods: CD14+ monocytes were cocultured with NLCs for 4 weeks and collected as NLC-supported CD14+ (NCD14+) monocytes. To determine their ability to differentiate into osteoclasts, NCD14+ monocytes were further cultured with macrophage colony-stimulating factor (M-CSF) together with RANKL or tumor necrosis factor alpha (TNFalpha). NCD14+ monocytes were also cocultured with SaOS-4/3 cells, which were shown to support osteoclastogenesis in response to parathyroid hormone (PTH). CD14+ monocytes were cocultured with SaOS-4/3 cells to elucidate how SaOS-4/3 cells and NLCs supported CD14+ monocytes for a long period. Synovial expansion adjacent to bone in RA patients was examined immunohistochemically to detect osteoclast precursors such as NCD14+ monocytes.
Results: NLCs supported the survival of CD14+ monocytes for 4 weeks. NCD14+ as well as CD14+ monocytes differentiated into osteoclasts in the presence of M-CSF together with RANKL or TNFalpha. NCD14+ monocytes also differentiated into osteoclasts in PTH-treated cocultures with SaOS-4/3 cells. SaOS-4/3 cells supported the survival of CD14+ monocytes for 4 weeks in the presence, but not absence, of PTH. Treatment of SaOS-4/3 cells with PTH up-regulated the expression of M-CSF messenger RNA. Neutralizing antibodies against M-CSF inhibited the NLC-supported survival of CD14+ monocytes. CD68+ monocytes and M-CSF+ fibroblast-like synoviocytes were colocalized in regions adjacent to the destroyed bone of RA patients.
Conclusion: Our findings suggest that NLCs are involved in RA-induced bone destruction by maintaining osteoclast precursors via production of M-CSF.
Similar articles
-
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.J Bone Miner Res. 2000 Sep;15(9):1766-75. doi: 10.1359/jbmr.2000.15.9.1766. J Bone Miner Res. 2000. PMID: 10976996
-
Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.Arthritis Rheum. 2004 May;50(5):1457-67. doi: 10.1002/art.20219. Arthritis Rheum. 2004. PMID: 15146415
-
[Molecular mechanisms of bone destruction in rheumatoid arthritis].Clin Calcium. 2007 Apr;17(4):510-6. Clin Calcium. 2007. PMID: 17404479 Review. Japanese.
-
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.Arthritis Res Ther. 2006;8(5):R152. doi: 10.1186/ar2046. Arthritis Res Ther. 2006. PMID: 16987426 Free PMC article.
-
[Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities].Pol Merkur Lekarski. 2007 Apr;22(130):300-4. Pol Merkur Lekarski. 2007. PMID: 17684931 Review. Polish.
Cited by
-
Mesenchymal stromal cells. Nurse-like cells reside in the synovial tissue and bone marrow in rheumatoid arthritis.Arthritis Res Ther. 2007;9(1):201. doi: 10.1186/ar2105. Arthritis Res Ther. 2007. PMID: 17306036 Free PMC article. Review.
-
Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA).J Bone Miner Metab. 2006;24(4):274-82. doi: 10.1007/s00774-006-0684-1. J Bone Miner Metab. 2006. PMID: 16816921
-
The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction.Immunology. 2009 Sep;128(1 Suppl):e315-24. doi: 10.1111/j.1365-2567.2008.02965.x. Epub 2008 Nov 19. Immunology. 2009. PMID: 19019090 Free PMC article.
-
In vitro osteoclastogenesis in autoimmune diseases - Strengths and pitfalls of a tool for studying pathological bone resorption and other disease characteristics.Heliyon. 2023 Nov 3;9(11):e21925. doi: 10.1016/j.heliyon.2023.e21925. eCollection 2023 Nov. Heliyon. 2023. PMID: 38034780 Free PMC article. Review.
-
Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.J Bone Miner Metab. 2009;27(1):24-35. doi: 10.1007/s00774-008-0013-y. Epub 2008 Dec 13. J Bone Miner Metab. 2009. PMID: 19082914
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials